Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

4 results

  • Understanding Vaccine Hesitancy at Montefiore Medical Center: Implications for Public Health Preparedness

  • Jared Shapiro, Adam Block, David Markenson
  • Journal:
    Disaster Medicine and Public Health Preparedness / Volume 19 / 2025
    Published online by Cambridge University Press:
    20 March 2025, e63
  • Objective

    Vaccine hesitancy among health care workers poses significant challenges to public health, particularly during times of crisis. This study investigates the factors influencing vaccine hesitancy among health care workers at Montefiore Medical Center, NY, with the aim of providing valuable insights to help shape and enhance future public health vaccination campaigns.

    Methods

    Utilizing Montefiore’s HER (Epic system) data from 2021–2023, linear logistic and multiple regression analyses were performed to assess correlations between demographic variables—such as age, race/ethnicity, job category, and county of residence—and vaccine uptake for both influenza and COVID-19 vaccines. Data were sourced from EPIC and Cority employee datasets. Missing demographic data were imputed where possible. The study population comprises a diverse workforce of 21 331 health care workers, encompassing a wide range of clinical and non-clinical roles.

    Results

    Key predictors of vaccine hesitancy included prior influenza vaccination status, age, race/ethnicity, job title, and county of residence. Workers vaccinated against influenza were 6.2% more likely to receive the COVID-19 vaccine. Younger health care workers and racial groups like Black and biracial employees demonstrated higher levels of hesitancy, while Asian workers exhibited higher rates of vaccine acceptance.

    Conclusions

    Tailored communication strategies and educational programs are critical for addressing vaccine hesitancy, particularly among younger health care workers and specific racial groups. Building trust and improving transparency will be essential to increasing vaccine uptake and achieving broader public health objectives.

  • 2 - US Integration of Government, Academia, and Industry

  • Michael J. Malinowski, Louisiana State University
  • Book:
    Personal Genome Medicine
    Published online:
    30 August 2023
    Print publication:
    31 August 2023, pp 73-123

  • Summary

    In the years following FDA approval of direct-to-consumer, genetic-health-risk/DTCGHR testing, millions of people in the US have sent their DNA to companies to receive personal genome health risk information without physician or other learned medical professional involvement. In Personal Genome Medicine, Michael J. Malinowski examines the ethical, legal, and social implications of this development. Drawing from the past and present of medicine in the US, Malinowski applies law, policy, public and private sector practices, and governing norms to analyze the commercial personal genome sequencing and testing sectors and to assess their impact on the future of US medicine. Written in relatable and accessible language, the book also proposes regulatory reforms for government and medical professionals that will enable technological advancements while maintaining personal and public health standards.

  • 5 - Vulnerability of the Science and Evidence Base of US Medicine

  • Michael J. Malinowski, Louisiana State University
  • Book:
    Personal Genome Medicine
    Published online:
    30 August 2023
    Print publication:
    31 August 2023, pp 202-298

  • Summary

    In the years following FDA approval of direct-to-consumer, genetic-health-risk/DTCGHR testing, millions of people in the US have sent their DNA to companies to receive personal genome health risk information without physician or other learned medical professional involvement. In Personal Genome Medicine, Michael J. Malinowski examines the ethical, legal, and social implications of this development. Drawing from the past and present of medicine in the US, Malinowski applies law, policy, public and private sector practices, and governing norms to analyze the commercial personal genome sequencing and testing sectors and to assess their impact on the future of US medicine. Written in relatable and accessible language, the book also proposes regulatory reforms for government and medical professionals that will enable technological advancements while maintaining personal and public health standards.

  • 1 - Medical Profession Sovereignty to Protect and Promote the Science and Evidence Base of US Medicine

  • Michael J. Malinowski, Louisiana State University
  • Book:
    Personal Genome Medicine
    Published online:
    30 August 2023
    Print publication:
    31 August 2023, pp 27-72

  • Summary

    In the years following FDA approval of direct-to-consumer, genetic-health-risk/DTCGHR testing, millions of people in the US have sent their DNA to companies to receive personal genome health risk information without physician or other learned medical professional involvement. In Personal Genome Medicine, Michael J. Malinowski examines the ethical, legal, and social implications of this development. Drawing from the past and present of medicine in the US, Malinowski applies law, policy, public and private sector practices, and governing norms to analyze the commercial personal genome sequencing and testing sectors and to assess their impact on the future of US medicine. Written in relatable and accessible language, the book also proposes regulatory reforms for government and medical professionals that will enable technological advancements while maintaining personal and public health standards.